Nimodipine is a medicine used to help prevent stroke after a certain type of head injury. It works by relaxing blood vessels in the brain, which can help reduce the risk of bleeding or swelling.
Every report comes from a Lived member, sent anonymously.
Have you tried Nimodipine for Subarachnoid Hemorrhage?
Nimodipine is a prescription medicine given after a subarachnoid hemorrhage caused by a ruptured brain aneurysm. A subarachnoid hemorrhage is bleeding into the space surrounding the brain, and an aneurysm is a weak, bulging spot in an artery wall that can burst. Nimodipine is used to improve recovery by lowering the chance and severity of brain injury from reduced blood flow (ischemia), a complication that can follow the bleed and is a frequent reason people recover less well. The approval applies however severe the person's condition is after the bleed. It comes as generic 30 mg capsules and as Nymalize, a ready-to-use liquid. Nimotop, the original capsule brand, is no longer sold in the US. Nimodipine belongs to the calcium channel blocker family, which includes several common blood pressure medicines, but its only US approval is for this situation. It is not a treatment for high blood pressure or a way to prevent other kinds of stroke.
Muscle cells in artery walls need calcium to tighten. Nimodipine blocks calcium from entering these cells, which lets blood vessels relax. In animal studies it acted more strongly on arteries in the brain than on arteries elsewhere, probably because it passes easily from the blood into brain tissue. After a subarachnoid hemorrhage, arteries near the blood can narrow (vasospasm), and parts of the brain can later receive too little blood. Nimodipine reduces the brain damage linked to this, but exactly how is not known: imaging studies have not shown that it prevents or reverses the artery narrowing itself. The body clears it quickly, which is why doses are given every four hours.
Nimodipine is given only by mouth or through a feeding tube into the stomach, such as a nasogastric tube placed through the nose. It must never be injected into a vein. Injecting the liquid from inside the capsules has caused cardiac arrest, a collapse in blood pressure and deaths, so when it is given by tube, the dose is drawn into an oral syringe that cannot take a needle. The usual adult dose is 60 mg every 4 hours, around the clock, for 21 days in a row. That is two 30 mg capsules or 10 mL of Nymalize per dose. Treatment should start as soon as possible and within 96 hours (four days) of the bleed. Each dose is given at least one hour before or two hours after a meal. People with liver cirrhosis receive half the usual dose, because a scarred liver clears less of the drug, along with close checks of blood pressure and pulse.
The most common problem is a drop in blood pressure. In clinical trials it affected about 4 in 100 people taking nimodipine, compared with about 1 in 100 taking a placebo, which is why blood pressure is checked regularly throughout treatment. Headache, nausea, a slower heartbeat, flushing and swelling from fluid retention can also occur. Dizziness, lightheadedness or feeling faint while taking nimodipine should be reported to the care team right away, since these can be signs that blood pressure has fallen too low.
Nimodipine is broken down by an enzyme in the liver and gut called CYP3A4. Medicines that strongly block this enzyme can raise nimodipine levels enough to cause a serious drop in blood pressure. They include the antibiotic clarithromycin, the antifungal medicines ketoconazole, itraconazole and voriconazole, certain HIV medicines such as ritonavir, and the antidepressant nefazodone. The capsule labels say not to combine them with nimodipine, and the Nymalize label says to generally avoid them. Grapefruit and grapefruit juice act in a similar way, with an effect that can last at least four days, so they should be avoided during treatment. The opposite problem comes from drugs that speed up the enzyme, including the seizure medicines carbamazepine, phenytoin and phenobarbital, the antibiotic rifampin and the herbal supplement St. John's wort. They can lower nimodipine levels enough to make it much less effective. Other blood pressure medicines can add to nimodipine's blood pressure lowering effect. There are no good studies in pregnant people, and animal studies showed harm to developing offspring, so use during pregnancy depends on whether the benefit justifies the risk. Nimodipine passes into breast milk; its effects on a breastfed baby are unknown.
Treatment starts in the hospital after the bleed, often while the person is too unwell to swallow, which is why it can be given through a feeding tube. The person will not feel it working. Its benefit is a lower chance of brain injury from reduced blood flow, not relief of symptoms such as headache. Blood pressure and heart rate are checked regularly, and the care team may adjust or stop the medicine if blood pressure falls too low. The full course is 21 days, even when the person is improving, and doses stay on a four-hour schedule because the drug wears off quickly. In pooled trials, oral nimodipine reduced the risk of a poor recovery by about a third compared with no calcium channel blocker. That result rests largely on one large trial, so reviewers describe the evidence as not beyond all doubt, but nimodipine remains standard treatment because the likely benefit is meaningful and the risks are modest. It lowers the chance of a poor recovery without removing it.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Nimodipine, what you've noticed, or ask the community a question.